0.5799
22-十一月-24 10:06:42
15 分钟延时
股票
+0.0099
+1.74%
今日范围
0.5700 - 0.5996
ISIN
N/A
来源
NASDAQ
AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina
08 11月 2024 05:00:00 条件 Nasdaq GlobeNewswire
AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy
22 12月 2023 06:00:00 条件 Nasdaq GlobeNewswire